Condition: Non Hodgkin Lymphoma · Heart; Functional Disturbance · Hodgkin Lymphoma · Sponsor: Wake Forest University Health Sciences
The purpose of this research is to test whether participating in either a physical activity intervention or a series of educational classes will help to preserve exercise capability, heart function, brain-based activities (like memory), and quality of life. Participants will be randomized to 1 of 2 pathways: * First pathway consists of organized health workshops. These workshops are intended to provide information on topics such as proper nutrition, management of stress, sleep practices, and emphasis on a healthy lifestyle that may help the participants through cancer treatment. This pathway will also test whether stretching may help participants through cancer treatment. * Second pathway participants will take part in some unsupervised and some potentially supervised moderate activity sessions each week throughout participants' cancer treatment to take place either remotely or in person, depending on availability of facilities at the time visits are scheduled.
This description comes directly from the study's public registry record.
Study Coordinator · 336-758-3027 · johnkc22@wfu.edu
Pamela J. Grizzard · 804-628-6234 · pamela.grizzard@vcuhealth.org
Always discuss trial participation with your own doctor first.
| Wake Forest Baptist Comprehensive Cancer Center | Winston-Salem, North Carolina, United States | Recruiting |
| Virginia Commonwealth University | Richmond, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05595577